Saltar al contenido
Merck
  • [Safety of thimerosal containing vaccines. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society].

[Safety of thimerosal containing vaccines. Statement of the Consultive Committee of Immunizations on behalf of the Chilean Infectious Diseases Society].

Revista chilena de infectologia : organo oficial de la Sociedad Chilena de Infectologia (2007-11-09)
Alma Muñoz M, Katia Abarca V, Jorge Jiménez de la J, Vivían Luchslnger F, Miguel O'Ryan G, Erna Ripoll M, M Teresa Valenzuela B, Rodrigo Vergara F
RESUMEN

Thimerosal is a mercury derivative included in vaccines since 1930 with the aim to prevent microbial contamination. During the last decades, the use of thimerosal has been questioned, specifically because of a potential association with neurotoxicity. After a thorough review of published studies on pediatric use of thimerosal-containing vaccines, and of position papers from international expert groups, the Consultive Committee of Immunizations of the Chilean Society of Infectious Diseases concludes that there is no solid evidence of adverse events associated with the use of thimerosal containing vaccines in infants and children. Therefore, a change in current vaccine practices refererred to thimerosal-containing vaccines is not justified in Chile.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Timerosal, 97.0-101.0% (on dried substance, titration)
En este momento no podemos mostrarle ni los precios ni la disponibilidad
Timerosal, European Pharmacopoeia (EP) Reference Standard
En este momento no podemos mostrarle ni los precios ni la disponibilidad